Clinical Trial Update: Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating colesevelam for bile acid malabsorption in Crohn's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Acid Malabsorption
• Crohn Disease

Drugs mentioned

• Colesevelam (colesevelam)

Snippet

Sponsor: Florian Beigel | Conditions: Crohns Disease, Bile Acid Malabsorption | Phase 4 | Status: TERMINATED